Overview

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin
Criteria
Inclusion Criteria:

- Must have met the inclusion criteria for the preceding double-blind study

- Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion Criteria:

- Cannot have absence seizures.